Ftse Mib
37.036,69
-0,23%
DAX
21.914,82
0,01%
S&P 500
6.083,57
0,36%
NASDAQ
19.791,99
0,51%
Bitcoin
97.466,13
0,92%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Pluri Inc (PLUR) Pluri Inc (PLUR) Notizie

Pluri Inc

PLUR
4,40
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 10:05:53
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
06/2/202513:30EDGAR2Form 8-K - Current report
04/2/202522:37EDGAR2Form SCHEDULE 13G/A - Statement of Beneficial Ownership by..
04/2/202513:00GLOBEPluri Secures Additional $3.5 Million Investment from Major..
29/1/202514:53EDGAR2Form 8-K - Current report
23/1/202513:15GLOBEPluri Secures $6.5 Million Strategic Investment at Premium..
21/1/202513:30EDGAR2Form 8-K - Current report
19/12/202414:00GLOBEPluri Congratulates Mesoblast on FDA Approval of First..
09/12/202415:00GLOBEPluri Shortlisted for CDMO of the Year Award by Advanced..
27/11/202422:15EDGAR2Form 8-K - Current report
25/11/202414:30GLOBEPluri Evaluates Readiness for Mass Production of PLX-R18 for..
28/10/202412:00GLOBEPluri Collaborates with Bar-Ilan University to Advance..
01/10/202414:00EDGAR2Form 8-K - Current report
20/9/202422:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/9/202422:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/9/202422:00EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
23/7/202413:30EDGAR2Form 8-K - Current report
18/7/202408:30GLOBEPluri’s CDMO Selected to Manufacture Kadimastem’s Novel Cell..
08/7/202413:30EDGAR2Form 8-K - Current report
08/7/202413:00GLOBEPluri Announces €1 Million Proof of Concept Agreement to..
18/6/202413:00EDGAR2Form 8-K - Current report
18/6/202412:30GLOBEPluri Subsidiary Ever After Foods Secured $10 Million..
06/6/202412:45GLOBEU.S. National Institutes of Health Exercises Option to Fund..
31/5/202422:05EDGAR2Form 8-K - Current report
20/5/202413:00GLOBENovel Medical Food Solution for the Elderly: Pluri & Wilk..
09/5/202422:13EDGAR2Form S-8 - Securities to be offered to employees in employee..
09/5/202422:10EDGAR2Form S-8 - Securities to be offered to employees in employee..
09/5/202422:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/5/202413:00GLOBEUnleashing the Power of MAIT Cells: Pluri Launches Novel..
08/4/202413:00GLOBEBreakthrough in Immune Cell Expansion: Pluri Granted U.S..
28/3/202412:15GLOBEPluri’s Business Verticals Gain Traction in Global Markets;..
27/3/202412:00GLOBEPluri Inc. Announces 1-for-8 Reverse Share Split
21/3/202412:00GLOBEPluri’s Sustainable Cell-Based Coffee Addresses Critical..
19/3/202409:00GLOBEEngage with Pluri's Talent: Exciting Conference Appearances..
14/3/202412:00GLOBEPluri Selected as CDMO by Remedy Cell for Cell-Derived..
11/3/202412:00GLOBEPluri™ Receives First-Ever Patent Approval for 3D Bioreactor..
06/3/202413:00GLOBEPluri Inc. Announces Appointment of Jim Roosevelt, Jr. to..
28/2/202413:00GLOBEPluri’s Innovation Across Various Industries: CEO Updates on..
13/2/202422:34EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/2/202422:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apertura: Min: Max:
Chiusura: 4,40

La tua Cronologia

NASDAQ
PLUR
Pluri
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci